Sharon di Stefano has spent 20 years as an analyst, beginning her career at Smith Barney, Harris Upham & Co. specializing in medical devices, pharmaceuticals, healthcare information technology, and biopharmacology. Ms. di Stefano had also served as Senior Venture Officer for the Edison Innovation Fund, implemented through the New Jersey Economic Development Authority that provided funding for early-stage life sciences companies. Industry experience includes laboratory research for Johns Hopkins Hospital and the Department of Defense.
Ms. di Stefano received a Masters of Science degree, in Business, from Johns Hopkins University in 1986, and a Bachelor of Arts from the University of Delaware in 1984 with a minor in biology.
I hold a Graduate Diploma in Applied Finance and Investment (similar to CFA), and a Graduate Diploma in Financial Planning.
I have 30 years of personal investing experience, and 15 years of professional financial advising experience, including broking experience at ETrade Australia, 7 years as a Senior Financial Planner at Commonwealth Bank of Australia and 8 years at High Net Worth Financial Advising. My business is a mix of young clients growing their wealth, pre-retirees, and retirees wanting income, some growth, and safety.As a global investor I use a macro thematic approach searching for good value and/or high growth. I search the globe for great investments with a focus on Asia, Emerging and Frontier Markets as well as "trend investing". I assess a countries demographics and growth potential. Some trends I currently follow include Chinese shares going global, the rising Asian middle class, Electric Vehicles, Renewable Energy, Energy Storage, Smartphones, 3D printing, and personal robots.
I also love to invest in income producing investments that can grow over time and benefit from compounding....Included here are the near monopoly businesses such as the Stock Exchanges, and the high quality income producers.
I use direct shares, ETFs, mutual funds and some direct property investments.
Zach is a biotech investor with PhD training in Biochemistry and Molecular Biology. In real life, he is a scientific writer specializing in continuing medical education. He hopes to provide a crucial piece of total due diligence as well as interesting insight into clinical findings that may impact readers' portfolios and lives.
Finsight Funds aims to bring a modern approach to investing by coupling data with the latest academic and proprietary research. In our interconnected world of Big Data, it should be easier than ever to identify trends and forces shaping markets.
I follow a blend of value and growth investing. The truly exceptional companies with great returns have growth ahead of them, but come at a value price.
I began investing in the stock market more than 10 years ago. I have experience working on the buy-side for a wealth management firm, a large asset management firm (which managed in excess of $50 billion) and a small hedge fund (AUM of $50m). I am a CFA Level 3 candidate for June 2017.
The purpose and mission for Finsight Funds is to help allocate financial resources where they can provide the most value to the world.
Part of the goal in writing for Seeking Alpha is to listen to and understand the readers to the research, thoughts, and ideas that are presented.
"He who listens becomes the master of what is profitable."
Recently, a reader asked about my anonymity. My response, which I feel is appropriate to share here, was:
"I have thought much about the distinction between myself as a PM and the institution I am founding; while I would love to have my institution accomplish a lot, I do not want resulting personal fame or attention. I would prefer to be out of the limelight. For those reasons, I have decided to promote the institution rather than myself."
The SA Marketplace is Seeking Alpha's platform for exclusive premium services from some of our top authors. Authors provide specialized, focused services that as a whole cover a wide variety of investment styles, giving readers a chance to get more insight on their preferred approach.
Check out all our authors here. This account will be used to highlight these authors and offer insights into investing from the authors to any interested users. Follow this account if you'd like to hear what's going on with the SA marketplace!
Nisha Hirani, M.D. is an experienced healthcare professional who serves as the Chief Scientific Advisor for Berg Capital Markets, LLC. In addition to her advisory role at Berg Capital Markets, LLC, Dr. Hirani currently works as a medical/healthcare industry consultant for NavMed Partners LLC. As a consultant, Dr. Hirani prepares proprietary client focused services including due diligence, valuation analysis, market research, and product research for biotechnology, pharmaceutical, healthcare staffing, healthcare IT and medical device companies, and is also a contributing writer for platforms such as Seeking Alpha and StockViews. Previously, Dr. Hirani worked as a biotechnology equity research analyst producing institutional quality equity research for under-valued and under-followed healthcare, biotechnology and medical device companies. Dr. Hirani’s initiating coverage reports, research reports and articles have been featured on both institutional and retail platforms including Thomson Reuters First Call, Bloomberg, Wall Street Source, Yahoo! Finance, Fidelity.com, and Google Finance. In the past, Dr. Hirani has taught embryology, performed research in the area of optical mammography, and taught English as a Second Language (ESL) classes. Dr. Hirani graduated from Tufts University with a B.S. in Biomedical Engineering and B.S in Biology, and received her Doctor of Medicine (M.D.) degree from St. George’s University School of Medicine. She completed her clinical clerkships primarily through the Barnabas Health System located in the New York Metropolitan area. In her free time, Dr. Hirani enjoys tennis, canvas painting, and volunteering for various non-profit organizations.
I'm retired from a near 40 year career in the publishing industry working with an international publishing company. My investing experience is over a span of 40 years. Luckily with more winners than losers! My hobbies are world travel, reading good books(non-fiction)--and researching stocks that I have an interest. In my retirement, I volunteer my time working in assisting several lawyers with their Child Protective Service cases.(Drugs are destroying our Society and family structure) I also serve as a reviewer for a national literary prize given each year.
BS in Economics, MA in Public Policy (International Economic Policy). J is a well-known voice in the global shipping community, with unparalleled investment results and a penchant for activist investing.
Mintzmyer founded Value Investor's Edge, a top-ranked deep value research service in May 2015, with the goal of establishing a top-tier community of deep value investors and activists. Value Investor's Edge subscribers leverage exclusive in-depth analytic reports and community investment experience to discover disconnects in global shipping and a variety of other beaten down sectors.
TipRanks.com ranked Mintzmyer’s performance in the top 3% of all global analysts at the end of 2015 for his 2-year investment performance. While compiling his research, Mintzmyer has interviewed numerous management teams at public maritime firms, and has worked with a multitude of investors. His exclusive analysis has received numerous 'Top Idea,' 'Must Read,' and 'Small Cap Insight' awards.
J is a CFA candidate and investment enthusiast who utilizes Seeking Alpha to provide an open exchange of both trading and investment ideas. Masters in Public Policy, with focus on International Security & Economic Policy from the University of Maryland, College Park. Distinguished Graduate of the United States Air Force Academy with a B.S. in Economics. President of Mintzmyer Investments LLC, a financial services company specializing in equity research and hedge fund advisory.
Extensive background in financial analysis, equity research, accounting, portfolio management, and customized asset allocation through nearly a decade of formalized education, personal studies, and practical experience. Avid reader of business/investments and biographies.
Legal Disclaimer: Any related contributions to Seeking Alpha, or elsewhere on the web, are to be construed as personal opinion only and do NOT constitute investment advice. An investor should always conduct personal due diligence before initiating a position. Provided articles and comments should NEVER be construed as official business recommendations. In efforts to keep full transparency, related positions will be disclosed at the end of each article to the maximum extent practicable. The majority of trades are reported live on Twitter, but this cannot be guaranteed due to technical constraints.
My premium service is a research and opinion subscription. No personalized investment advice will ever be given. I am not registered as an investment adviser, nor do I have any plans to pursue this path. No statements should be construed as anything but opinion, and the liability of all investment decisions reside with the individual. Although I do my utmost to procure high quality information, investors should always do their own due diligence and fact check all research prior to making any investment decisions. Any direct engagements with readers should always be viewed as hypothetical examples or simple exchanges of opinion as nothing is ever classified as “advice” in any sense of the word.
I am a retired 20 year Wall Street $ manager. I specialized in fixed income, equity positioning with covered call writing hedging strategies. My experience is finding undervalued or oversold companies, taking a long position and writing a covered call to increase my monthly returns. Over time this strategy has outperformed most with minimizing risk.
I began after college in retail DIY home Improvement (paint/tile/wallpaper/etc.) with Colortile - div. Tandy and moved on to retail electronic with CMC. In these positions I was in the top 5% of regional sales 30 out of 31 months. A customer recruited me into LM Berry and selling Yellow Page advertising. I was then recruited into managing a four state area for American Building Company in 1984. After ABC faced possible indictment after a questionable LBO I moved on to manage a large advertising account base for Consolidated Communications, Inc. for two years. I started my own business in 1992. We developed and grew a product initially offered through retailers - at one opoint over 300 - but closed out large facility and moved home selling though direct fulfillment to end users (to increase profits).
Our products are based on utility Patents awarded me by the USPTO. I'm still cutting, shaping, sanding, finishing and selling a line of specialty hardwood tools for needlework and embroidery end users. My wife and I have done better as a couple working out of our homw than we did with a large employee count and accompanying regulations, taxes, and expenses.
I enjoy astronomy with a collection of really nice telescopes from a 4" apochromatic refractor to Classic Cave Astrola 12.5" Newtonian to a Meade LX200 14" Autostar. I treasure annual visits to the dark skies at the west end of the Oklahoma panhandle; observing in Tulsa is not very productive.
I drive a very nice, 1994 Acura NSX with racing suspension and "massaged" motor and brakes; it is a nice road circuit car.
Together Laura and I have slowly been turning our yard into a beautiful parklike garden with stone work, island planters and a watercourse under construction.
We have become debt free except for a small revolving credit ballance and a hard working margin account returning a significant worthwhile return. I am semi-retired as is Laura. Daughter married to Physicist. Son is in upper ED phase. Wife is an avid needleworker. We share gardening and landscaping; our home is a project in the works. I am the family chef and baker.
I also am a firearm "enthusiast" and target shooter. I am especially fond of my ancient Mossberg .22 144 LSA -
Born June 27th 1935 in Vienna, Austria. The youngest singer in my family which sang with the von Trapp singers, of which the film Sound of Music was based. Maria (played by Julie Andrew) was actually my nanny before she married Capt von Trapp (played by Christopher Plumber) who was not in the navy of Austria since Austria, being a land locked country, had no navy.
The little boy "Kurt" in the film was actually me. My mom never sued Twentieth Century Fox for using our story without receiving payment. (the von Trapps never went over the Alps to Switzerland.. that was my family and me...the captain and his singing family went to Italy and from there came to America via London)
When arriving in USA we moved to Arlington VT. where my neighbor was Norman Rockwell. My mom disallowed me from sitting for him despite frequent invitations to do so. Second immortality lost. :-)
Graduated with honors(Wall Street Journal award) from Lafayette College in 1957. After attending med school became ER physician in Conn. hospital, on the night shift. Had a seat on the NYSE at the same time and commuted from the hospital to Wall Street daily. After a few years of this, left medicine to stay with the NYSE Stock exchange.
Was also partner with Leon Cooperman in a NYSE member firm in late sixties. Carl Ichan and other notables of Wall Street are on best friends list..
Traded money for many well known names on the street such as Peter Kellogg of Spear Leeds and Kellogg, etc.
Am only surviving founder of the CBOE opened In early 70's. Names of "stripp, strapp, iron condor, condor, straddle, strangle" were all names that were thought up and first used by me. Traded options long before the CBOE was founded.
Traded on the CBOE under acronym PPP (known as Peter Paul) till 1988.
Started a Classic Jaguar restoration company in 1988 till 2011.
Went back to trading my own account, off floor in 2008.
60 years trading experience. Have been an avid technician the entire 60 years. We use fundamentals, PE ratios, overall market conditions, Fibonacci retracements, Elliott Wave theory, my own mathematical formulas as well as my own technical chart work (5 minute, daily, weekly as well as yearly) charts in analyzing and preparing recommendations to buy sell or hold.
ALL OUR ARTICLES are and will contain material discussion on timing and will be geared for the short term trader as well as the long term investor. I am on my computers, monitoring live charts and financial news on a minute to minute basis every trading day, from pre-market trading opening to after-market trades and the final closing.
Unlike Seeking Alpha articles from other contributors, all our articles will be prepared for maximum gain and minimum loss by supplying sell and buy stop recommendations along with the original recommendation. These will be updated as necessary over future time intervals. All will be published and added to all our recommendations on an "as needed" basis as often as market forces cause the need for such alterations. The use of option strategies as adjuncts or substitutions for stock will also be used and discussed as well as updated as necessary, so the investor taking our advise will never be out there "on his own" after acting on our initial recommendation from Doc's Trading"..
Readers may contact me directly at: email@example.com or (cell)928 951 4779
I am an engineer and long time technical consultant specializing in control and instrumentation systems for medical, industrial, vehicle and aerospace companies. The technical, cultural, market, regulatory and other factors that separate successful products and companies from their peers has fascinated me for many years. My investment experience is limited to my own accounts.
INDEPENDENT Financial Advisor / Professional Investor- with over 30 years of navigating the Stock market's "fear and greed" cycles that challenge the average investor. Investment strategies that combine Theory, Practice and Experience to produce Portfolios focused on achieving positive returns over a period of time. Providing advice in helping to avoid the pitfalls and traps that wreak havoc on your portfolio with a focus on Income and Capital Preservation.
I manage the capital of only a handful of families and I see it as my number one job to protect their financial security. They don’t pay me to sell them investment products, beat an index, abandon true investing for mindless diversification or follow the Wall Street lemmings down the primrose path. I manage their money exactly as I manage my own so I don’t take any risk at all unless I strongly believe it is worth taking.
Blogging here on SA is part of my research. I write to find out what I think.
I invite you to join the family of satisfied clients send an e-mail :firstname.lastname@example.org
Individual investor for 30 years, now Full-Time. MD degree. Trade daily. Long stocks only, and call options, mainly LEAPs, which I consider to be long term investments. I am a patient investor. My core is biopharma, with a few biotechs: Together, these comprise about 75% of my portfolio, and include some large core biopharmas, as well as aggressive emerging biopharmas, which I call my "Baby Bios." Of these, DEPO has sprouted wings. Others have been active of late. There is also eclectic diversification, with some retail, clothing, tech, software.. I trade daily, and look for newly listed options. [Please note that there is no check box for "Healthcare" in the "Your Interests" section].
An astute researcher that has come to some brilliant conclusions on insignificant pieces of the Universe. In particular one little company called Antares Pharma. This is primarily due to owning share of the company way to long, because I knew way to much about ATRS. Never imagined the share price would have dropped into 2 buck range, as Oct 28, 2014. So it must be that investors do not know what ATRS is really up to? Figured, someone needs to step up and let the small investors know what the large investment firms know about Antares Pharma, because they have the research power. Therefore, Loko for the little investors...suggest you make use of it.....or lose it.... Donations are welcome, in shares of ATRS of course.....
Sirius Capital is a Biotech Portfolio Management firm specializing in mid term investments in clinical stage biotech and pharma companies.
Our analysts combine their extensive experience in Pharma and drug development with financial management expertise to yield maximal profit to our clients.
I'm 32, invest in the light of the Austrian economic tradition, which in today's environment means mostly precious metals and mining stocks using cycles and sentiment as timing mechanisms. ETF's, options, I also own some physical. I've been doing this independently for 3 years. I reserve a small chunk of my portfolio for speculating in biotech and technology where I believe appropriate.
75 year history of Palms & Company http://www.intota.com/viewbio.asp?bioID=765681&perID=722170 Google Profile: http://google.com/profiles/GlobalEconomicMeltdown 2014 Google Profiles: https://plus.google.com/u/0/111530479647791972928/about?pop=wv&hl=en_US Author Understanding Russian Banking 300 pages 1997 ISBN 0-9645464-2-6 Available on Amazon, Non de Plum Pyotr Joannevich Van de Waal -Palms Purchased by World Bank & International Monetary Fund References http://PeterPalms.com/credentials U.S. Citizen http://peterPalms.com/russia as well as http://PeterPalms/africa or /china article contributor to http://opednews.com commentator on 50+ U.S. Newspapers, Chinese, Indian, Russian, African http://PeterPalms.com/credentials
Mr. Dugger has worked in biotechnology and food production industries and with the critical resource limitations related to global food production for more than 40 years. He is a recognized expert in the economic relationships between critical resources like energy as it pertains to other critical resources such as the production and process of fertilizer components such as NPK and their impacts on food production.
Mr. Dugger was educated as a marine biologist, a graduate of Florida Atlantic University with extensive independent management training (military and AMA) during his 40+ year career he has contributed to commercial biotechnology development through research and business development, environmental impact analyses, and economic feasibility analyses. His most recent and ongoing professional activities include:- The development and integration of multi-species/multi-trophic aquaculture (ISRAS) as an effective peak resource and energy efficiency tool in the quest for being the most competitive (sustainable, economically efficient and least cost aquaculture food producer).
- Serves as Marine Biotechnology Development Specialist - Grape Bay Capital and Oceanis Fund Advisory Boards.
- The economic feasibility analysis of spiny lobster production technology and critical path development strategies.
- Developed an economic and sustainability development pathway analysis of biofuels - particularly for algae based biofuel aquaculture based on his commercial algae production experience through most of the past 40 years.(http://seekingalpha.com/article/1475791-the-bloom-is-off-npk-produced-algae-biofuel-development).
- During his career he has provided technical consulting services, technology audits, product development and testing, marketing studies, startup and project management for Fortune 500 new venture projects (Ralston Purina, Sun Oil Co., AMFAC, General Foods, Inc., International Protein, Inc.) mid-sized private companies (MRW Inc., ImmuDyne Inc., Zeigler Bros. Inc., Syndel Inc.) numerous private companies/investors, international development banks and funds (Agro-21, Jamaican National Bank, Asian Development Bank, Canadian Development Bank, Overseas Private Investment Corp. OPIC. Rockefeller Brothers Fund, Grape Bay Capital), Federal and state demonstration programs (US Army Corps. Of Engineers, City of Eastham, MA, University of FL and the FL Dept. of Ag., FL Dept. of Transportation) and his own companies.
In addition, he has taught a variety of biotechnology, economic and aquaculture related courses for Harbor Branch Oceanographic Institution, American Soy Bean Association and as an invited guest speaker at energy conferences such as the 2009 AIAA (American Institute of Aeronautics and Astronautics - invitation by NASA) and at local colleges. He has written and presented technical papers to the World Aquaculture Association (WAS), research journals, trade publications and blogs. He was a Vice-President, board member of the World Aquaculture Society for 8 years as well as serving on the WAS Journals editorial and review staff. He is listed under "Collaborator and Consultants" on the NASA OMEGA (Offshore Membrane Enclosure for Growing Algae) project.
Mr. Dugger services have been solicited as an expert witness by legal firms in biotechnology related cases including for the state of Florida and he has provided Congressional testimony regarding the development of the aquaculture industry in the US. He has been President and CEO of BioCepts International, Inc. since 1996.
I am an individual investor who has been actively involved in the healthcare and biotechnology space for over 15 years. I hold a PhD in the biomedical sciences and have worked in both large pharmaceutical and small biotech companies. I make investments based on the fundamentals of a company and if I believe they have a superior technology or products compared to the competition. I'm an investor who believes patience pays off.
I am the Chief of Operations at Wolfram Solutions, the consulting arm of the large privately held software company, Wolfram Research. I manage teams of programmers developing custom applications for business and, government, applying advanced analytic methods to practical challenges. I played a major role in the development of many of the financial features of Mathematica and Wolfram|Alpha. I have been at Wolfram for over 15 years. My academic background is in the social sciences and analytic methods in the social sciences, including finance, economics, statistics, modeling, simulation, and operations research. I studied at the University of Chicago, both undergrad and grad. I am also an individual investor with 30 years experience, mostly using mutual funds and fundamental analysis, plus specific investments in the financial sector. My contributions on Seeking Alpha focus on the financial sector and monetary economics, and what analysis of those areas can tell us about other macro trends. I also discuss portfolio theory, formal methods in finance, modeling and simulation of financial prices and economic time series, government statistical releases, financial regulation, and monetary policy.
I am an investor relations consultant with 25+ years experience steering IR strategy and outreach for over 100 companies across a range of industries. We launched Catalyst Global in early 2012 to serve as a platform for innovating the IR role to better address the radically different dynamics and needs of public companies and investors.
Catalyst's mission is combining senior level experience and counsel with targeted outreach and efficient communications to deliver real change and share price results for "smidcap" companies in today's markets. We understand relationships and credibility take time, and we root all our work in integrity, candor and a focus on ROI.
I post on Seeking Alpha to expand the reach of client and other investment stories we like - and to understand the nature of these new channels of communication. Networking ideas and working with new media is integral to the IR function - plus it's fun.
CG Focus List is a separate service we use to highlight specific investment stories brought to us by some of the really smart investors we know. Profiled companies can be clients, ex-clients, non-clients or desired clients - but they are stories that offer very attractive investment potential and commensurate risk (there's no free ride in investing!)
My posts are NOT endorsed by the Companies on which I write - client or otherwise. We believe in truth and fair play at all times, and at all costs, and gravitate to those who share that view.
I am now retired from the US pharma industry having spent over 33 years in the Mid-Atlantic corridor in Sales(Hospital mainly), Scientific Relations and Managed Care/LTC. I worked at BMY, Bayer/Miles Labs and SGP/MRK prior to early retirement..
Today I enjoy investing in Bio-Pharmas mostly, because it is what I know best!
I invest mostly in large companies such as BMY, PFE, MRK, GSK, and JNJ (love the divis) but I like the up and coming Bios like CLDX. Cancer and Immunotherapy intrigues me..so I have made that a major consideration since 2008....With BARDA,the GAIN act and QDIP Ive come to appreciate the Antibiotic cos.and have made them a major component of my LT strategy to build wealth while in Retirement....Ive invested in Trius(TSRX),CBST, CEMP, DRTX, TTPH, CTIX and just added AKAO.....
I manage personal monies and some family members..gratis of course!